Drug name - Rayos
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8309124 | HORIZON | Delayed release tablet with defined core geometry |
Apr, 2024
(1 year, 6 months from now) | |
| US8394407 | HORIZON | Delayed release tablet with defined core geometry |
Apr, 2024
(1 year, 6 months from now) | |
| US9040085 | HORIZON | Delayed release tablet with defined core geometry |
Apr, 2024
(1 year, 6 months from now) | |
| US9186332 | HORIZON | Delayed release tablet with defined core geometry |
Apr, 2024
(1 year, 6 months from now) | |
| US9504699 | HORIZON | Delayed-release glucocorticoid treatment of rheumatoid disease |
Aug, 2027
(4 years from now) | |
| US8168218 | HORIZON | Delayed release tablet with defined core geometry |
Jan, 2028
(5 years from now) | |
Drugs and Companies using PREDNISONE ingredient
Treatment: Treatment of diseases or conditions by the use of a delayed release 1, 2, or 5 mg prednisone tablet; Treatment of diseases or conditions by the use of a delayed-release 1,2, or 5mg prednisone tablet; Treatment of rheumatologic, allergic, pulmonary, gastrointestinal, dermatologic diseases or conditions by the use of a delayed release 5mg prednisone tablet
Dosage: TABLET, DELAYED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1MG | TABLET, DELAYED RELEASE;ORAL | Prescription |
| 2MG | TABLET, DELAYED RELEASE;ORAL | Prescription |
| 5MG | TABLET, DELAYED RELEASE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.